Skip to content Skip to menu

In partnership with key stakeholders, Medicines Australia drives the creation and development of an environment for the continued sustainable growth of the innovative research based prescription medicines industry

About Us

97 per cent of Aussies want new cancer medicines subsidised through PBS

New findings released by Newspoll [i] shows overwhelming support for access to new cancer medicines through the Pharmaceutical Benefits Scheme (PBS), for Australian patients. Newspoll found 97 per cent of Australians strongly support the subsidisation of cancer medicines for curable cancers, including 95 per cent supporting medicines that ease symptoms and extend the life of […]

View article· March 24, 2015

New research shows Australia lags far behind other countries in access to new medicines

A new report released today shows Australians are missing out on too many new medicines,with Australia ranked 18th out of 20 comparable OECD countries. The COMPARE report – Comparison of Access and Reimbursement Environments –benchmarks Australia’s access to new medicines and will be launched at the National Press Club today by Medicines Australia Chairman, Dr […]

View article· March 18, 2015

Government and industry partnership key to future of PBS

Medicines Australian Chairman, Dr Martin Cross has welcomed ongoing collaboration between the pharmaceutical industry and Government in addition to further improvements to the Governments post-market review programme, which was announced today by the Minister for Health, the Hon Sussan Ley.  “This framework for post-market reviews is the result of collaboration between the Government and Medicines […]

View article· March 18, 2015

Fear Mongering Jeopardising “21st Century” Trade Deal

The Trans Pacific Partnership Agreement (TPP) will open up vast new markets for Australian companies, including manufacturers of innovative medicines and vaccines, Medicines Australia CEO, Tim James, said today.  “Pharmaceuticals are already one of Australia’s largest manufactured export, worth around $3 billion each year.  “But a new trade deal which further reduces trade barriers, improves […]

View article· March 16, 2015

Medicines Australia presents Ethics Awards for top sales representatives

Thirteen medical sales representatives from the Australian medicines industry received the sector’s top accolade for ethical sales and marketing at a ceremony yesterday. The Medicines Australia Continuing Education Program Awards are presented annually to sales representatives who achieve the best marks in their compulsory ethical conduct education program. Medicines Australia Chief Executive Officer, Mr Tim […]

View article· March 13, 2015

IGR confirms the sustainability of the PBS into the future

The release of the highly anticipated 2015 Intergenerational Report (IGR) today reaffirmed the growing body of evidence that shows that the Pharmaceutical Benefits Scheme (PBS) is sustainable. CEO of Medicines Australia, Tim James, welcomed the release of the Australian Government’s 2015 IGR, and its acknowledgement that growth in pharmaceutical expenditure will remain stable, growing only […]

View article· March 5, 2015

Australian cancer patients in deadly wait for new medicines

Australian cancer patients don’t have time to wait for access to new cancer medicines. Australian patients wait longer for access to new cancer medicines compared to patients in other parts of the world, such as the United Kingdom, Canada, France and Germany. “Australia is the cancer capital of the world.  We are now living much […]

View article· February 26, 2015

Access, Value and Investment: The key for Australian patients and the future of the medicines Industry

Medicines Australia has lodged a submission to the 2015-16 Federal Budget. In the Submission, Medicines Australia calls on the Australian Government to recognise the ongoing sustainability of the Pharmaceutical Benefits Scheme (PBS), resulting from reforms introduced in collaboration with the industry. Medicines Australia also seeks a commitment to grow the investment opportunities for innovation and […]

View article· February 12, 2015

Medicines Australia congratulates outgoing PBAC Chair on her new role at WHO

Medicines Australia CEO, Tim James, congratulates Dr Suzanne Hill, Chair of the Pharmaceutical Benefits Advisory Committee (PBAC), on her new role with the World Health Organization. Today the Minister for Health, the Hon Sussan Ley MP, announced that Dr Hill will step down from her role as Chair of the PBAC following the March PBAC […]

View article· February 5, 2015

The PBS is a sustainable, valuable & cost-effective investment in Australia’s future health and prosperity

Medicines Australia’s critical analysis of successive Intergenerational Reports (IGR) demonstrates that previous successive IGRs seriously overestimated PBS expenditure as a proportion of GDP, and highlights the pitfalls of ignoring significant reforms undertaken in the prescription medicines sector over the last decade. “Analysis released today confirms that the PBS is sustainable and is well placed to […]

View article· February 4, 2015

Papers, Reports & Submissions


Agreements, Indemnity & Compensation Guidelines

Clinical Trials

Awards, Speeches & Media Releases

Media & Events

Member company lounge

Member's Area

Sign up for updates

Sign up for email updates to keep on top of Medicines Australia developments.


RT @PharmaInFocusAu: News: @MedicinesAus CEO @timothycjames weighs in on #biosimilars in Australia - leave it to the TGA. #healthpolicy htt…

RT @timothycjames: Looking forward to addressing @RareVoices Rare Diseases Summit tomorrow! @MedicinesAus a proud sponsor. #RareDisease #ph

97 per cent of Aussies want new cancer medicines subsidised through PBS

Modernising the current regulatory and reimbursement system must be a priority today #cancerdrugsau

Improve timely and affordable access to cancer medicines for all Australian cancer patients #cancerdrugsau

“Advances in medicines improve the lives of ordinary people" Senator @Deborah_ONeill #cancerdrugsau

Patients,academics,meds industry & other stakeholders face significant challenges-system for access to meds needs modernising #cancerdrugsau

RT @timothycjames: Great for @MedicinesAus and MedicinesNZ collaborate - Chairs together today - @MMMXXX and @HeatherRoyNZ #pharma http://t

RT @sussanley: Great to catch up with a broad range of groups at Medicines Aus Dinner @MedicinesAus @CHFofAustralia @CancerDrugsAu http://t

Prof Deborah Schofield @ceda_news "Invest strategically in health to save money and drive productivity" #valueofmedicines #healthpolicy

"Invest strategically in ways to increase productivity" Professor Deborah Schofield #valueofmedicines #healthpolicy @ceda_news

#healthpolicy "Health drives labour force participation" Professor Deborah Schofield #valueofmedicines @ceda_news